CB, yes it was good to hear from both doctors last
Post# of 148282
So its very likely if COVID-19 approval comes it may very well be before the HIV approval so I can see why so much attention and direction from the entire Cytodyn team is putting into this, of course its high priority as well from a saving lives stand point.
Think about what happens if COVID-19 gets approved, this sets the stage for all other possible indications we will have in the works since its the same drug, nothing changes except dosage and treatment plans based on whats being treated.
So we have two revenue possibilities this year, HIV and now COVID-19, to me its just a matter of which one gets approved first. The BLA submission will do wonders for investor sentiment surrounding CYDY, and hoping April 2020 we can all say its completed !!!